Trials / Conditions / Recurrent Primary Amyloidosis
Recurrent Primary Amyloidosis
3 registered clinical trials studyying Recurrent Primary Amyloidosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis NCT03499808 | SWOG Cancer Research Network | Phase 2 |
| Active Not Recruiting | Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis NCT03283917 | M.D. Anderson Cancer Center | Phase 1 |
| Unknown | Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapse NCT03252600 | Barbara Ann Karmanos Cancer Institute | Phase 2 |